论文部分内容阅读
将肝细胞膜上无唾液酸糖蛋白受体所能识别的配基作为载体与药物相结合获得肝靶向药物，可使药物选择地导向肝细胞，提高疗效，降低副作用。本文着重介绍无唾液酸糖蛋白受体介导的肝靶向药物的作用机制、药物载体及应用
The liver cell membrane asialoglycoprotein receptor recognized by the ligand as a carrier and drug combination to obtain liver-targeting drugs, the drug can be selectively targeted to the liver cells to improve efficacy and reduce side effects. This article focuses on the mechanism of asialoglycoprotein receptor-mediated liver-targeting drugs, drug carriers and applications